<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558010</url>
  </required_header>
  <id_info>
    <org_study_id>CHW-Methadone-001</org_study_id>
    <nct_id>NCT02558010</nct_id>
  </id_info>
  <brief_title>Perioperative Methadone Use to Decrease Opioid Requirement in Pediatric Spinal Fusion Patients</brief_title>
  <official_title>Perioperative Methadone Use to Decrease Opioid Requirement in Pediatric Spinal Fusion Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute pain management following major surgical procedures in pediatric patients continues to
      be a challenge, especially after extensive posterior spine fusions.

      Spine surgery is particularly traumatic, initiating pain in both peripheral and central
      pathways. While the standard management of post-surgical pain involves a multimodal approach,
      opioids provide the predominant benefit. However, opioid use is associated with many adverse
      effects, including nausea, constipation, and pruritus. Perioperative methadone may decrease
      total opioid consumption and adverse effects as well as improve satisfaction with pain
      management after scoliosis repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a double blind comparison, evaluating the benefits of intraoperative methadone
      in extensive posterior spine fusion surgery for idiopathic scoliosis. Methadone 0.2 mg/kg
      will be given to the treatment group. Postoperative evaluation for narcotic use, pain
      control, and adverse effects will be compared to a standard treatment approach used at
      Children's Hospital of Wisconsin.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Pain Score on the verbal numeric pain scale</measure>
    <time_frame>72 hours</time_frame>
    <description>Scores range from 0 (no pain) - 10 (worst possible pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Itching as assessed by number of doses of benadryl required post-operatively</measure>
    <time_frame>72 Hours</time_frame>
    <description>Number of doses benadryl per patient over 3 post-op days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction as assessed by the question &quot;How satisfied were you with your pain management?&quot;</measure>
    <time_frame>72 hours</time_frame>
    <description>Responses can range from 0 (very dissatisfied) to 10 (very satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea as assessed by number of doses of ondansetron required post-operatively</measure>
    <time_frame>72 hours</time_frame>
    <description>Number of doses ondansetron per patient over 3 post-op days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation as assessed by number of days to first bowel movement</measure>
    <time_frame>72 hours</time_frame>
    <description>Number of days to first bowel movement will be recorded for each patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Scoliosis</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Methadone Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a total of 0.2mg/kg IV methadone intraoperative (0.1mg / kg preincision and 0.1mg/kg prior to emergence) with a maximum dosing of 20 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive normal saline placebo initially, then morphine prior to emergence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>perioperative IV methadone to be given</description>
    <arm_group_label>Methadone Group</arm_group_label>
    <other_name>generic methadone only</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>control arm</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>salt water</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Both groups will receive morphine via Patient-Controlled Analgesia pump.</description>
    <arm_group_label>Methadone Group</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 10-17 years

          -  Idiopathic scoliosis

          -  Fusion levels of 10 or greater

          -  English speaking

          -  American Society of Anesthesiology (ASA) class 1 and 2

        Exclusion Criteria:

          -  Current narcotic use / History of substance abuse

          -  Morphine, hydromorphone or methadone allergies

          -  Pregnancy

          -  Seizure Disorders

          -  Bleeding disorders

          -  Non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Weisman, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital and Health System Foundation, Wisconsin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger A Fons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital and Health System Foundation, Wisconsin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Keri Hainsworth, PhD</last_name>
    <phone>414266-6306</phone>
    <email>khainsworth@chw.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ellen Edwards, BS</last_name>
    <email>eedwards@mcw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger A Fons, MD</last_name>
      <phone>414-266-3561</phone>
      <email>rfons@mcw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Keri Hainsworth, PhD</last_name>
      <phone>4142666306</phone>
      <email>khainsworth@chw.org</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Weisman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger Fons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berde CB, Beyer JE, Bournaki MC, Levin CR, Sethna NF. Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. J Pediatr. 1991 Jul;119(1 Pt 1):136-41.</citation>
    <PMID>2066846</PMID>
  </reference>
  <reference>
    <citation>Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.</citation>
    <PMID>20418538</PMID>
  </reference>
  <reference>
    <citation>Rusy LM, Hainsworth KR, Nelson TJ, Czarnecki ML, Tassone JC, Thometz JG, Lyon RM, Berens RJ, Weisman SJ. Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial. Anesth Analg. 2010 May 1;110(5):1393-8. doi: 10.1213/ANE.0b013e3181d41dc2.</citation>
    <PMID>20418301</PMID>
  </reference>
  <reference>
    <citation>Sharma A, Tallchief D, Blood J, Kim T, London A, Kharasch ED. Perioperative pharmacokinetics of methadone in adolescents. Anesthesiology. 2011 Dec;115(6):1153-61. doi: 10.1097/ALN.0b013e318238fec5.</citation>
    <PMID>22037641</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2015</study_first_submitted>
  <study_first_submitted_qc>September 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2015</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Roger A Fons, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Methadone</keyword>
  <keyword>Gabapentin</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Posterior Spinal Fusion</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

